Allogeneic cell therapy of severe beta thalassemia major by displacement of host stem cells in mixed chimera by donor blood lymphocytes

Bone Marrow Transplantation

Volumn 19, Issue SUPPL. 2, 1997, Pages 96-98

  Kapelushnik, J ^a   Or, R ^a   Aker, M ^a   Cividalli, G ^a   Nagler, A ^a   Naparstek, E ^a   Varadi, G ^a   Ackerstein, A ^a   Amar, A ^a   Slavin, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBULIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; BETA THALASSEMIA; BLOOD TRANSFUSION; CASE REPORT; CHILD; CHIMERA; CONFERENCE PAPER; FEMALE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030942417     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. GIARDINI C, ANGELUCCI E, LUCARELLI G et al. Bone marrow transplantation for thalassemia: experience in Pesaro, Italy. Amer J Pediatr Hemat/Oncol 1994, 16(1):6-10.
2. LUCARELLI G, CLIFE RA, GALIMBERTI M et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood 1996, 87:2082-2088.
3. NESCI S, MANNA M, ANDREANI M, FATTORINI P, GRAZIOSI G, LUCARELLI G. Mixed chimerism in thalassemic patients after bone marrow transplantation. Bone Marrow Transp 1992, 10:143.
4. MANNA M, NESCI S, ANDREANI M, TONUCCI P, LUCARELLI G. Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients. Bone Marrow Transpl 1993, 12:70.
5. FRASSONI F, STRADA P, SESSAREGO M et al. Mixed chimerism after allogeneic marrow transplantation for leukemia: correlation with dose of total body irradiation and graft versus host disease. Bone Marrow Transplant 1990, 5:235-240.
6. KAPELUSHNIK J, OR R, FILON D et al Analysis of β-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood 1995, 86:3241-3246.
7. DI BARTOLOMEO P, GIROLAMO GD, ANGRILLI F et al. Second marrow transplants in patients with thalassemia major rejecting the first graft.
8. OR R, KAPELUSHNIK J, NAPARSTEK E et al. Second transplantation using allogeneic peripheral blood stem cells in a β-thalassemia major patient featuring stable mixed chimerism. Brit J Hemai 1996, 94:285-287.
9. SLAVIN S, NAPARSTEK E, NAGLER A, ACKERSTEIN A, KAPELUSHNIK J, OR R. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes. Exp Hematol 1995, 23:1553-1562.
10. ROY DC, TANTRAVAHI R, MURRAY C et al. Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood 1990, 75:296-304.
11. DURNAM DM, ANDERS KR, FISHER L, O'QUIGLEY J, BRYANT EM, THOMAS ED. Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989, 6: 2220-2226.
12. TRUITT RL, ATASOYLU AA. Impact of pretransplant conditioning and donor T cells on chimerism, graft versus host disease, graft versus leukemia reactivity, and tolerance after bone marrow transplantation. Blood 77, 2515-2523.
13. VAN DEN BOS C, KIEBOOM D, WAGEMAKER G. Correction of murine β-thalassemia by partial bone marrow chimerism: Selective advantage of normal erythropoiesis. Bone Marrow Transp 1993, 12:9.
14. WAGEMAKER G, VISSER TP, VAN BEKKUM DW. Cure of murine thalassemia by bone marrow transplantation without eradication of endogenous stem cells. Transplantation 1986,42:248.